Reduction of risk for mortality and morbidity in suspected sepsis – in 15 minutes

The Sepsis Biomarker
A short monograph
» Automated quantitative POC method
» From 100 μl whole blood or plasma in 15 minutes
» For early monitoring of effectiveness of antibiotic treatment
» Superior prognostic value for risk assessment of patients
» Excellent performance demonstrated in numerous studies
» Multi marker testing with other analytes possible

NEW SEPSIS MARKER

PATHFAST® PRESEPSIN
» Diagnosis & early prognosis
» Risk stratification
» Patient monitoring
PATHFAST® PRESEPSIN is a chemiluminescent enzyme immunoassay for the quantitative measurement of presepsin concentration in whole blood or plasma. PATHFAST® PRESEPSIN can be used as an aid in the diagnosis and prognosis of sepsis, in the assessment of the degree of septic severity, and in the risk stratification of critically ill septic patients.
Clinical use of PATHFAST® PRESEPSIN
» Early diagnosis and prognosis of sepsis
» Prognosis already at fi rst presentation
» For emergency and intensive care use

Diagnosis & early prognosis

Exclusion of sepsis or infection < 200 pg/ml
Exclusion of severe sepsis or septic shock ≤ 300 pg/ml
Sepsis possible  > 300 pg/ml
High probability of severe sepsis or septic shock  > 1000 pg/ml

Risk stratification & patient monitoring

Quartile 1st (n=37)

 

2nd (n=35)

 

3rd (n=35)

 

4th (n=33)
 

Presepsin (pg/ml)

 

 

177 – 512 524 – 927 950 – 1,810 1,850 – 15,757
Mortality (p<0.0001)

 

2.7% 8.6% 17.1% 39.4%

PATHFAST®

A Compact immunoanalyzer with superior assay performance

Also available :markers for cardiac emergencies

  • PATHFAST® cTnI
  • PATHFAST® Myoglobin
  • PATHFAST® CK-MB
  • PATHFAST® D-Dimer
  • PATHFAST® NTproBNP
  • PATHFAST® hsCRP
  • PATHFAST® HCG

Sepsis diagnostics

  • Presepsin

Fertility reagents

  • Hcg preg
  • LH
  • Estradiol
  • Progesterone
  • FSH
  • Prolactin